ASSESSMENT OF THE USE OF TRANEXAMIC ACID AFTER TOTAL KNEE ARTHROPLASTY
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | LEITE, Chilan Bou Ghosson | |
dc.contributor.author | RANZONI, Lucas Verissimo | |
dc.contributor.author | GIGLIO, Pedro Nogueira | |
dc.contributor.author | BONADIO, Marcelo Batista | |
dc.contributor.author | MELO, Lucas Da Ponte | |
dc.contributor.author | DEMANGE, Marco Kawamura | |
dc.contributor.author | GOBBI, Riccardo Gomes | |
dc.date.accessioned | 2020-06-01T14:54:52Z | |
dc.date.available | 2020-06-01T14:54:52Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Objective: To evaluate the profile of blood loss and blood transfusions after the introduction of Tranexamic acid (TXA) in a tertiary university hospital in Brazil. Methods: 173 patients were retrospectively divided into two groups: the ones who received TXA and the control group. Hemoglobin levels (Hb), drain output, transfusion rates, and thromboembolic events were measured. Results: Among the patients included in this study, 82 cases received TXA. Blood transfusion occurred in 3 cases of the TXA group (3.7%), and in 27 control group cases (29.7%; p < 0.001). The average Hb decrease was 2.7 g/dl (+/- 1.39) and the median drain output was 270 mL in the TXA group. In the control group, the values were 3.41 g/dl (+/- 1.34; p < 0.001) and 460 mL (p < 0.001), respectively. Thromboembolic events occurred in 2 TXA group cases (2.4%) and in 3 control group cases (3.3%; p > 0.999). Conclusion: TXA was effective in reducing blood transfusion rates, Hb decrease, and drain output on the 1st postoperative day without increasing thromboembolic events. | eng |
dc.description.index | PubMed | eng |
dc.identifier.citation | ACTA ORTOPEDICA BRASILEIRA, v.28, n.2, p.74-77, 2020 | |
dc.identifier.doi | 10.1590/1413-785220202802228410 | |
dc.identifier.eissn | 1809-4406 | |
dc.identifier.issn | 1413-7852 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/36024 | |
dc.language.iso | eng | |
dc.publisher | ATHA COMUNICACAO & EDITORA | eng |
dc.relation.ispartof | Acta Ortopedica Brasileira | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright ATHA COMUNICACAO & EDITORA | eng |
dc.subject | Tranexamic Acid | eng |
dc.subject | Blood Transfusion | eng |
dc.subject | Knee Replacement Arthroplasty | eng |
dc.subject.other | blood-loss | eng |
dc.subject.other | prophylaxis | eng |
dc.subject.other | strategies | eng |
dc.subject.other | safe | eng |
dc.subject.other | hip | eng |
dc.subject.wos | Orthopedics | eng |
dc.title | ASSESSMENT OF THE USE OF TRANEXAMIC ACID AFTER TOTAL KNEE ARTHROPLASTY | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 6 | |
hcfmusp.contributor.author-fmusphc | CHILAN BOU GHOSSON LEITE | |
hcfmusp.contributor.author-fmusphc | LUCAS VERISSIMO RANZONI | |
hcfmusp.contributor.author-fmusphc | PEDRO NOGUEIRA GIGLIO | |
hcfmusp.contributor.author-fmusphc | MARCELO BATISTA BONADIO | |
hcfmusp.contributor.author-fmusphc | LUCAS DA PONTE MELO | |
hcfmusp.contributor.author-fmusphc | MARCO KAWAMURA DEMANGE | |
hcfmusp.contributor.author-fmusphc | RICCARDO GOMES GOBBI | |
hcfmusp.description.beginpage | 74 | |
hcfmusp.description.endpage | 77 | |
hcfmusp.description.issue | 2 | |
hcfmusp.description.volume | 28 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 32425668 | |
hcfmusp.origem.scielo | SCIELO:S1413-78522020000200074 | |
hcfmusp.origem.scopus | 2-s2.0-85083792771 | |
hcfmusp.origem.wos | WOS:000528274000005 | |
hcfmusp.publisher.city | SAO PAULO SP | eng |
hcfmusp.publisher.country | BRAZIL | eng |
hcfmusp.relation.reference | Alshryda S, 2011, J BONE JOINT SURG BR, V93B, P1577, DOI 10.1302/0301-620X.93B12.26989 | eng |
hcfmusp.relation.reference | Drosos GI, 2016, J ORTHOP, V13, P127, DOI 10.1016/j.jor.2016.03.007 | eng |
hcfmusp.relation.reference | Henry DA, 2011, COCHRANE DATABASE SY | eng |
hcfmusp.relation.reference | Huang ZY, 2018, TRANSFUSION, V58, P1855, DOI 10.1111/trf.14783 | eng |
hcfmusp.relation.reference | Januel JM, 2012, JAMA-J AM MED ASSOC, V307, P294, DOI 10.1001/jama.2011.2029 | eng |
hcfmusp.relation.reference | Jiang T, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-019-1270-2 | eng |
hcfmusp.relation.reference | Kim TK, 2014, KNEE SURG SPORT TR A, V22, P1849, DOI 10.1007/s00167-013-2487-y | eng |
hcfmusp.relation.reference | Levine BR, 2014, J AM ACAD ORTHOP SUR, V22, P361, DOI 10.5435/JAAOS-22-06-361 | eng |
hcfmusp.relation.reference | Melvin JS, 2015, J AM ACAD ORTHOP SUR, V23, P732, DOI 10.5435/JAAOS-D-14-00223 | eng |
hcfmusp.relation.reference | Pabinger I, 2017, WIEN KLIN WOCHENSCHR, V129, P303, DOI 10.1007/s00508-017-1194-y | eng |
hcfmusp.relation.reference | Riaz O, 2019, J ORTHOP TRAUMATOL, V20, DOI 10.1186/s10195-019-0534-2 | eng |
hcfmusp.relation.reference | Sabbag OD, 2017, J ARTHROPLASTY, V32, pS246, DOI 10.1016/j.arth.2017.02.008 | eng |
hcfmusp.relation.reference | Sassoon A, 2016, BONE JOINT J, V98B, P173, DOI 10.1302/0301-620X.98B2.36776 | eng |
hcfmusp.relation.reference | Su EP, 2016, BONE JOINT J, V98B, P98, DOI 10.1302/0301-620X.98B.36430 | eng |
hcfmusp.relation.reference | Tanaka N, 2001, J BONE JOINT SURG BR, V83B, P702, DOI 10.1302/0301-620X.83B5.11745 | eng |
hcfmusp.relation.reference | Tang YF, 2019, INT J SURG, V65, P45, DOI 10.1016/j.ijsu.2019.03.011 | eng |
hcfmusp.relation.reference | Whiting DR, 2014, CLIN ORTHOP RELAT R, V472, P66, DOI 10.1007/s11999-013-3134-0 | eng |
hcfmusp.relation.reference | Wong J, 2010, J BONE JOINT SURG AM, V92A, P2503, DOI 10.2106/JBJS.I.01518 | eng |
hcfmusp.relation.reference | Xu S, 2019, THROMB RES, V176, P61, DOI 10.1016/j.thromres.2019.02.006 | eng |
hcfmusp.relation.reference | Yang ZG, 2012, J BONE JOINT SURG AM, V94A, P1153, DOI 10.2106/JBJS.K.00873 | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | dd5ecf21-f7f4-4d60-bb70-223a242c1a93 | |
relation.isAuthorOfPublication | 0e69853e-24e2-48c7-8970-5fe3cc06f3b9 | |
relation.isAuthorOfPublication | ab18aafd-6c36-4ab3-bd26-a0f4fe463d26 | |
relation.isAuthorOfPublication | 26976d1d-63b4-49cc-96c7-b502040b7e22 | |
relation.isAuthorOfPublication | ea82026a-631e-4117-a800-7f6cee0a2c20 | |
relation.isAuthorOfPublication | 319595de-3c3e-413e-9c9a-9e024d254190 | |
relation.isAuthorOfPublication | ba1883c8-000e-4940-856d-8bb7f45791eb | |
relation.isAuthorOfPublication.latestForDiscovery | dd5ecf21-f7f4-4d60-bb70-223a242c1a93 |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_LEITE_ASSESSMENT_OF_THE_USE_OF_TRANEXAMIC_ACID_AFTER_2020.PDF
- Tamanho:
- 200.51 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)